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Hes5 regulates the transition timing of neurogenesis and
gliogenesis in mammalian neocortical development
Shama Bansod1,2, Ryoichiro Kageyama1,2,3,4 and Toshiyuki Ohtsuka1,2,3,*
ABSTRACT
During mammalian neocortical development, neural stem/progenitor
cells (NSCs) sequentially give rise to deep layer neurons and
superficial layer neurons through mid- to late-embryonic stages,
shifting to gliogenic phase at perinatal stages. Previously, we found
that the Hes genes inhibit neuronal differentiation and maintain
NSCs. Here, we generated transgenic mice that overexpress Hes5 in
NSCs of the central nervous system, and found that the transition
timing from deep to superficial layer neurogenesis was shifted earlier,
while gliogenesis precociously occurred in the developing neocortex
of Hes5-overexpressing mice. By contrast, the transition from deep to
superficial layer neurogenesis and the onset of gliogenesis were
delayed in Hes5 knockout (KO) mice. We found that the Hmga genes
(Hmga1/2) were downregulated in the neocortical regions of Hes5-
overexpressing brain, whereas they were upregulated in theHes5 KO
brain. Furthermore, we found that Hes5 expression led to suppression
of Hmga1/2 promoter activity. These results suggest that Hes5
regulates the transition timing between phases for specification of
neocortical neurons and between neurogenesis and gliogenesis,
accompanied by alteration in the expression levels of Hgma genes, in
mammalian neocortical development.
KEY WORDS: Hes5, Hmga, Neurogenesis, Gliogenesis, Neocortical
development, Mouse
INTRODUCTION
Neural stem/progenitor cells (NSCs) sequentially give rise to deep
layer neurons and later to superficial layer neurons; at late
embryonic stages, NSCs terminate neurogenesis and shift to
gliogenesis. As such, NSCs temporally alter their characteristics,
and the timing of the generation of a variety of neurons and glial
cells is strictly regulated (McConnell, 1989; Temple, 2001; Ohtsuka
et al., 2011). Growing evidence implicates the involvement of
epigenetic regulatory systems in the regulation of this transition
timing. The polycomb group (PcG) complex of transcriptional
repressors has been found to govern the developmental timing of
neurogenesis and gliogenesis by modulating histones and chromatin
structure during corticogenesis (Vogel et al., 2006; Hirabayashi
et al., 2009; Schwartz and Pirrotta, 2013; Pereira et al., 2010;
Morimoto-Suzki et al., 2014; Corley and Kroll, 2015). Moreover, it
has been reported that the high mobility group AT-hook (Hgma)
genes regulate gene expression by modulating chromatin structure
(Ozturk et al., 2014), maintain neurogenic NSCs, and inhibit
gliogenesis during early- to mid-embryonic stages through global
opening of the chromatin state (Kishi et al., 2012). However, the
mechanism by which the expression of these epigenetic factors is
controlled remains to be analyzed.
Here, we found that Hes5, a transcriptional repressor acting
as an effector of Notch signaling, regulates the timing of
neurogenesis and gliogenesis via alteration in the expression
levels of epigenetic factors. Notch signaling contributes to the
elaboration of cellular diversity during the development of various
tissues (Kopan et al., 1994; Robey et al., 1996; Weinmaster, 1997;
Gridley, 1997; Artavanis-Tsakonas et al., 1999). In addition, in the
central nervous system (CNS), Notch signaling governs various
developmental processes, such as maintenance of NSCs, neurite
outgrowth of cortical neurons, and neuronal versus glial fate
choice (de la Pompa et al., 1997; Berezovska et al., 1999; Tanigaki
et al., 2001). We previously found that some members of the Hes
gene family of basic helix-loop-helix (bHLH) transcriptional
repressors (Hes1/3/5) function downstream of Notch signaling and
inhibit neuronal differentiation (Ishibashi et al., 1994; Ohtsuka
et al., 1999, 2001; Kageyama and Ohtsuka, 1999; Hatakeyama
et al., 2004). NSCs initially expand as neuroepithelial cells by
symmetric proliferative divisions and then transform to radial
glial cells (RGCs), a neurogenic form of NSCs, after switching
to asymmetric neurogenic divisions. After this transition,
differentiating neurons express Notch ligands such as Delta-like
(Dll) and Jagged (Jag), and trigger a boost of Notch-Hes signaling
in NSCs. Expression of Hes5 is upregulated in RGCs after the
onset of neurogenesis, when NSCs start to receive strong
intercellular Delta-Notch signals from differentiating and mature
neurons (Hatakeyama et al., 2004). Thus, Hes5 is a key regulator of
the maintenance of NSCs after the transition to the asymmetric
neurogenic division mode.
To more precisely uncover the diverse role of Hes5 throughout
the course of neocortical development, we generated transgenic
(Tg) mouse lines in which Hes5 expression in NSCs could be
manipulated by the Tet-On system. In the Hes5-overexpressing Tg
mice, neuronal differentiation from NSCs was strongly inhibited,
while the switching from deep to superficial layer neurogenesis was
shifted earlier, and gliogenesis was also accelerated and enhanced.
By contrast, the transition of neurogenesis and gliogenesis was
delayed in the Hes5 knockout (KO) mice. We found that expression
of Hmga1/2 was suppressed in the neocortical regions of Tg brain;
conversely, their expression was upregulated in the Hes5 KO brain.
Furthermore, we found that Hes5 expression led to suppression of
the promoter activity of Hmga1/2 in reporter assays. These results
suggest that Hes5 regulates the switching of both neurogenesis and
gliogenesis, accompanied by alteration in the expression levels of
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Overexpression of Hes5 maintained NSCs by inhibiting
neuronal differentiation
To manipulate Hes5 expression in NSCs, two Tg mouse lines were
generated (Fig. 1A). rtTA was driven in NSCs by the promoter and
second intron of the nestin (Nes) gene (pNes-rtTA Tg). In the
presence of doxycycline (Dox), rtTA binds to the Tet-responsive
element (TRE) and bidirectionally activates expression of Hes5 and
d2EGFP (TRE-Hes5/d2EGFP Tg). By crossing both lines, Hes5-
overexpressing Tg mice were generated, and Dox (2.0 mg/ml in
drinkingwater) was continuously administered to pregnant mice from
embryonic day (E) 9.5 until sacrifice. Thewhole-body and brain sizes
were smaller in the Tg mice than in the wild-type (WT) mice, and
GFP was highly expressed in the central nervous system, including
the brain, retina and spinal cord (Fig. 1B). Notably, olfactory bulbs
were frequently missing in the Tg brains in which Hes5 and GFP
were highly expressed (Fig. 1B, arrows). We confirmed by in situ
hybridization that Hes5 expression was enhanced in the ventricular
zone (VZ) and subventricular zone (SVZ), in which GFP was highly
expressed (Fig. 1C). Real-time RT-PCR revealed that expression of
Hes5mRNA increased byE10.5 whenDoxwas administered starting
at E9.5 (Fig. 1D). GFP overlappedwith Pax6, a marker for NSCs, and
partially overlapped with Tbr2, a marker for intermediate progenitor
cells (IPs), and Tuj1, a neuronal marker, in the dorsolateral
telencephalon (neocortical regions) (Fig. 1E). Noticeably,
the lateral ventricles and the VZ (Pax6+) were dilated, and the
thicknesses of neuronal layers (Tuj1+) were markedly thinner in the
Tg brain compared to the WT brain (Fig. 1F). Tbr2+ IPs in the SVZ
were reduced in number, and the thickness of the cortical plate (CP),
which consists of NeuN+ differentiated neurons, was also reduced
in the Tg brain at all developmental stages examined (Fig. 1G-J),
indicating that Hes5 overexpression led to maintenance and
expansion of NSCs by inhibiting neuronal differentiation.
However, analysis of neurogenesis/gliogenesis at postnatal stages
was difficult because the Tg mice could not survive after birth,
although the cause of death is unknown.
Hes5 overexpression suppressed proliferation of neural
progenitors
Although neuronal differentiation was inhibited and NSCs were
maintained longer in the Tg brain, the brain size was rather reduced
(Fig. 1B). Therefore, we analyzed cell death and cell proliferation
activity in neural progenitors in the neocortical regions.
Immunostaining with anti-cleaved caspase-3 antibodies revealed
that cell death was slightly enhanced in the neocortical regions of Tg
brain (Fig. S1A). Next, we assessed cell proliferation by conducting
5-bromo-2′-deoxyuridine (BrdU) incorporation experiments and
immunostaining with antibodies against Ki67, a marker of
proliferating cells, and phospho-histone H3 (pH3), a marker of
dividing cells in M phase. BrdU was administered intraperitoneally
to pregnant mice 30 min before sacrifice at E13.5 or E15.5 to mark
cells that incorporated BrdU in S phase. Although the number of
Ki67+ cells was rather increased in the Tg brain at E13.5, BrdU+ and
pH3+ cells were decreased in number in the neocortical regions of
Tg brain compared to WT brain (Fig. S1B). Later, at E15.5, the
numbers of BrdU+ and pH3+ cells were markedly reduced in the
neocortical regions of Tg brain compared to WT brain (Fig. S1C),
indicating that proliferating cells and dividing cells were reduced
in number in the Tg brain. These results suggested that cell
proliferation activity was suppressed by Hes5 overexpression, thus
leading to unexpectedly smaller brain size in the Tg mice. Next, we
analyzed self-renewal versus cell cycle exit of NSCs in the WT and
Tg brains. We administered 5-ethynyl-2′-deoxyuridine (EdU)
intraperitoneally to pregnant mice at E14, and characterized EdU+
cells by immunostaining with anti-Pax6, Tbr2, Tuj1 and Ki67
antibodies 12 h later at E14.5. A higher proportion of EdU-
incorporated cells remained as Pax6+ NSCs in the Tg brain
compared to the WT brain (Fig. S2A,B), whereas more EdU+ cells
were colabeled with Tbr2 and Tuj1 in the WT brain than in the Tg
brain (Fig. S2C-F). In line with these observations, the proportion of
Ki67+;EdU+/EdU+ (cell cycle re-entry) was higher in the Tg cortex,
whereas the proportion of Ki67−;EdU+/EdU+ (cell cycle exit) was
higher in the WT cortex at E14.5 (Fig. S2G,H). Taken together,
these results indicated that the frequency of self-renewal of NSCs
was higher in the Tg cortex than in the WT cortex.
The thicknesses of all cortical layers were reduced
in the Tg cortex
Next, we analyzed the expression of Hes1 and neurogenic bHLH
genes such as Neurog2 and Ascl1. Expression levels of Hes1
(protein and mRNA) and Neurog2 mRNA were downregulated in
the VZ of neocortical regions of Tg brain (Fig. 2A,B), while Ascl1
expression in the neocortical regions was not significantly altered,
indicating that Hes5 overexpression could repress Neurog2 and
inhibit neuronal differentiation even when Hes1 activity was
attenuated. This result is consistent with the notion that Hes1 and
Hes5 show compensatory expression patterns in the developing
nervous system through mutual repression of their transcription
(Hatakeyama et al., 2004). In addition, we found that the thicknesses
of all cortical layers were reduced in the Tg brain by using markers
for layers II-IV (Cux1), layer V (Ctip2) and layer VI (Tbr1) neurons
at E15.5 and postnatal day 0 (P0) (Fig. 2C-E). Furthermore,
reduction in the expression level of Fezf2, a fate determinant of
Ctip2+ neurons, which correspond to subcerebral projection neurons
(SCPNs), was demonstrated by in situ hybridization (Fig. 2F). Real-
time RT-PCR using total RNAs prepared from the neocortical
regions revealed that expression levels of Tbr1, Ctip2 (Bcl11b –
Mouse Genome Informatics) and Fezf2 were significantly
downregulated in the Tg brain at E14.5 and E16.5 (Fig. 2G).
However, Cux1 expression was not significantly changed, probably
because it was maintained in the VZ/SVZ (Fig. 2C). It is likely that
the suppressed proliferation of neural progenitors via Hes5
overexpression led to the reduced thicknesses of all cortical layers
and smaller brain size in the Tg mice.
Switching from deep to superficial layer neurogenesis
precociously occurred in the Tg mice
Next, we performed birth-date analysis by administering EdU
intraperitoneally to pregnant mice. When EdU was injected at
E10.5, more EdU+ cells, which were born during the period of EdU
exposure, were found as layer VI neurons (Tbr1+) in the Tg cortex at
E18.5, suggesting an earlier onset of neurogenesis in the Tg brain
compared to the WT brain (Fig. S3A,B). When EdU was
administered at E11.5, most EdU+ cells were located in layer VI
(Tbr1+) of the WT brain, while more EdU+ cells were observed in
layer V (Ctip2+) of the Tg brain compared to the WT brain
(Fig. S3C-F). When EdU was injected at E12.5, most EdU+ neurons
were still located in layer VI (Tbr1+) but not in layer V (Ctip2+) of
the WT cortex at E18.5 (Fig. 3A,B). By contrast, EdU+ cells were
distributed in layer VI (Tbr1+), layer V (Ctip2+), and further upper
layers of the Tg cortex, suggesting that Ctip2+ layer V and further
upper layer neurons were born prematurely in the Tg brain. In the
WT brain, when EdU was injected at E13.5, the majority of EdU+
cells were located in layer V (Ctip2+), while some were in layers
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Fig. 1. Brain morphology of Hes5-overexpressing Tg mice. (A) Structure of pNes-rtTA and TRE-Hes5/d2EGFP transgenes. (B) Comparison of whole body
(E13.5) and brain (E18.5) shape of WT and Hes5-overexpressing Tg mice. Dox was administered from E9.5 onward. GFP expression was detected throughout the
CNS under a fluorescent microscope. Note that the olfactory bulbs were missing in the Tg brain (arrows), in which Hes5 and GFP were highly expressed.
(C) Immunohistochemistry using anti-GFP antibodies to detect GFP (green), and in situ hybridization forHes5mRNA expression (purple), in coronal sections of the
WT and Tg telencephalon at E15.5. (D) Quantitative real-time RT-PCR using total RNAs prepared from the telencephalon of WT and Tg embryos at the indicated
stages. Dox was administered from E9.5 onward. Gapdh was used as an internal control, and the values were normalized to that of the WT sample at each
stage. (E) Characterization of Hes5/d2EGFP-expressing cells. Coronal sections of the neocortical regions of E15.5 Tg embryos were double stained using anti-GFP
(green) and anti-Pax6/Tbr2/Tuj1 (red) antibodies. The boxed areas are magnified in the right panels, and merged images are further magnified in the rightmost
panels. (F) Tuj1 (green) and Pax6 (red) staining in coronal sections of the WT and Tg telencephalon at various developmental stages. (G,H) Tbr2 staining (red) in
coronal sections of the WT and Tg telencephalon at the indicated stages (G), and quantification of Tbr2+ cell number in a radial column of 200 µm width in the
neocortical regions (H). DAPI (blue) was used for nuclear staining. (I,J) NeuN staining (green) in coronal sections of the neocortical regions at the indicated stages (I),
and quantification of the thickness of CP (NeuN+) (J). (F,G,I) The boxed areas in photos at E15.5 aremagnified in the rightmost panels. (D,H,J)Data aremean±s.e.m.
(n=3); *P<0.05, **P<0.01, ***P<0.001, ****P<0.0001, *****P<0.00001 (Student’s t-test). Scale bars: 1 mm in B; 200 µm in C, E, F, G and I.
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II-IV (Cux1+) (Fig. 3C,D). By contrast, in the Tg brain, the majority
of EdU+ cells were distributed in layers II-IV (Cux1+), while some
were in layer V (Ctip2+), suggesting that Cux1+ layer II-IV neurons
were born prematurely in the Tg brain. When EdU was injected at
E14.5, most EdU+ cells were settled in layers II-IV (Cux1+) of both
WT and Tg brains (Fig. 3E,F). These results indicated that Hes5
overexpression accelerated the switching from deep to superficial
layer neurogenesis.
Fig. 2. Expression of neurogenic bHLH genes and generation of layer-specific neurons. (A) Immunohistochemistry for the bHLH repressor Hes1 (red), and
in situ hybridization for mRNA expression of the neurogenic bHLH genes Neurog2 and Ascl1 (purple), in coronal sections of the telencephalon of WT and Hes5-
overexpressing Tg mice at E15.5. (B) Quantitative real-time RT-PCR using total RNAs prepared from the neocortical regions of WT and Tg embryos at
E14.5.Gapdhwas used as an internal control. (C,D) Immunohistochemistry using layer-specific markers (Cux1 for layers II-IV, Ctip2 for layer V, and Tbr1 for layer
VI) in coronal sections of the neocortical regions at E15.5 (C) and P0 (D). The border between the VZ and SVZ is indicated bya dotted line. (E) Graphs showing the
numbers of Cux1+, Ctip2+ and Tbr1+ cells in a radial column of 200 µm width at P0. (F) In situ hybridization for mRNA expression of Fezf2 in coronal
sections of the WT and Tg telencephalon at E14.5. (G) Real-time RT-PCR using total RNAs prepared from the neocortical regions of WT and Tg embryos at
E14.5, E16.5 and E18.5. Expression levels of Tbr1, Ctip2, Fezf2 and Cux1 were compared between WT and Tg brains. Gapdh was used as an internal control.
(B,E,G) Data are mean±s.e.m. (n=3); *P<0.05, **P<0.01, ***P<0.001, ****P<0.0001 (Student’s t-test). Scale bars: 200 µm.
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Astrogenesis was accelerated and enhanced in the Tg brain
We next addressed whether the onset of gliogenesis was likewise
accelerated in the neocortical regions by Hes5 overexpression.
Although expression of GFAP (a marker for astrocytes) was not
observed in the neocortical regions of WT mice at E17.5, a
considerable number of GFAP+ astrocytes precociously appeared in
Fig. 3. Analyses of the transition timing of layer-specific neurogenesis and gliogenesis in the Hes5-overexpressing Tg brain. (A,C,E) Birth-date analysis
of cortical neurons in WT and Tg brains. EdU was administered at E12.5 (A), E13.5 (C) or E14.5 (E), and the locations and fates of EdU-incorporated cells (red)
were examined by the layer-specific markers Tbr1/Ctip2/Cux1 (green) at E18.5. (B,D,F) Graphs showing the proportions of each layer-specific neurons
among EdU+ cells. Total numbers of EdU+ cells counted for the quantification were ≥100 cells for each analysis. (G) Analysis of generation of astrocytes in the
neocortical regions of WT and Tg brains at E17.5 and P0. Double staining was performed using anti-GFAP (red) and anti-GFP (green) antibodies in coronal
sections. (H) Real-time RT-PCR for GFAP expression using total RNAs prepared from the neocortical regions of WT and Tg brains at E16.5 and E18.5.
Gapdh was used as an internal control. (B,D,F,H) Data are mean±s.e.m. (n=3); *P<0.05, **P<0.01 (Student’s t-test). Scale bars: 200 µm.
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the neocortical regions of Tg mice (Fig. 3G). Whereas GFAP signal
was present in the neocortical regions ofWTmice at P0, the number
of GFAP+ astrocytes was markedly higher in the VZ/SVZ and
throughout the cortex of Tg mice. Most GFAP+ cells coexpressed
GFP in the VZ/SVZ, but many GFAP+ cells in the outer region were
GFP−, suggesting that the outer region GFAP+ cells lost Hes5/
d2EGFP expression over the course of glial differentiation. Real-
time RT-PCR demonstrated thatGFAP expression was significantly
higher in the neocortical regions of Tg brain at E16.5 and E18.5
(Fig. 3H). These results indicated that astrogenesis was accelerated
and enhanced by Hes5 overexpression. In addition, we analyzed the
generation of oligodendrocyte lineage cells with antibodies against
Olig2, a marker for oligodendrocytes, and found that the numbers of
Olig2+ cells were reduced in the neocortical regions of Tg brain
compared to WT brain at E17.5 and E18.5 (Fig. S4). This might be
attributed to the hypoplastic ventral telencephalon (Fig. 1F), which
is the primary source of oligodendrocyte progenitor cells.
Transition timing of layer-specific neurogenesis and
astrogenesis was delayed in the absence of Hes5
Subsequently, we performed birth-date analysis in the neocortical
regions of Hes5 KO mice (Ohtsuka et al., 1999; Hatakeyama et al.,
2004). When EdUwas injected at E10.5 or E11.5, we did not find any
significant difference in early neurogenesis between the WT and KO
mice (data not shown). However, when EdU was injected at E14.5,
most EdU+ cells were located in layers II-IV (Cux1+), but not in layer
V (Ctip2+), of theWT cortex, whereas EdU+ cells were predominantly
distributed in layer V (Ctip2+), and fewer EdU+ cells were located in
layers II-IV (Cux1+) of the Hes5 KO cortex, at E18.5 (Fig. 4A,B),
indicating that the switching from deep to superficial layer
neurogenesis was delayed in the Hes5 KO brain. In addition,
immunohistochemistry and real-time RT-PCR for GFAP expression
revealed the delayed onset of astrogenesis in the neocortical regions of
Hes5 KO brain compared to WT brain at E18.5 (Fig. 4C,D). These
results exhibited striking contrast to the accelerated neurogenesis and
astrogenesis observed in the Hes5-overexpressing Tg mice.
Hmga genes were downregulated by overexpression
of Hes5
Because it has been found that PcG complex and Hmga proteins
govern the developmental timing of neurogenesis and gliogenesis,
we assessed their expression levels in the Hes5-overexpressing Tg
brain. Real-time RT-PCR demonstrated upregulation of Ezh2 and
Eed, components of polycomb repressive complex 2 (PRC2), in
the neocortical regions of Tg brain at E12.5 (Fig. 5A), whereas
the expression of Ring1B (Rnf2 – Mouse Genome Informatics), a
Fig. 4. Estimation of the transition timing of neurogenesis and
astrogenesis in Hes5 KO mice. (A) Birth-date analysis in the
neocortical regions of WT and Hes5 KO brains. EdU was
administered at E14.5, and the locations and fates of EdU-
incorporated cells (red) were examined by the layer-specific
markers Ctip2 and Cux1 (green) at E18.5. (B) Graphs showing the
proportions of Ctip2+ cells and Cux1+ cells among EdU+ cells. Total
numbers of EdU+ cells counted for the quantification were ≥100
cells for each analysis. (C) Analysis of generation of astrocytes
using anti-GFAP antibodies (red) in the neocortical regions of WT
and Hes5 KO brains at E18.5. Arrows indicate GFAP expression in
the VZ. (D) Real-time RT-PCR for mRNA expression ofGFAP using
total RNAs prepared from the neocortical regions of WT and KO
brains at E18.5. Gapdh was used as an internal control. (B,D) Data
are mean±s.e.m. (n=4); **P<0.01, ****P<0.0001 (Student’s t-test).
Scale bars: 200 µm.
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component of PRC1, was not significantly affected. In situ
hybridization also demonstrated a subtle increase in the
expression levels of both genes in the neocortical regions of Tg
brain at E12.5 (Fig. S5A,B). Notably, expression levels of Hmga1
and Hmga2 were significantly reduced in the Tg brain compared to
the WT brain (Fig. 5B). We confirmed by in situ hybridization that
the expression of both Hmga1 and Hmga2 was remarkably
downregulated in the neocortical regions of Tg brain compared to
WT brain (Fig. 5C). Conversely, expression levels of Hmga1 and
Hmga2 were upregulated in the neocortical regions of Hes5 KO
brain compared to WT brain (Fig. 5D,E). Expression levels of
Hmga1/2 in the ventral telencephalon, diencephalon, midbrain and
hindbrain were not much altered in the Tg brain, although the
brain shape was apparently deformed compared to that of the WT
Fig. 5. Altered expression levels of Hmga1/2 in the neocortical regions. (A,B) Real-time RT-PCR using total RNAs prepared from the neocortical regions of
WT and Hes5-overexpressing Tg brains. mRNA levels of PcG components, such as Ezh2, Eed and Ring1B (A), and Hmga1 and Hmga2 (B), were quantified at
E12.5, E14.5 and E18.5. (C,D) In situ hybridization for Hmga1 and Hmga2 mRNA expression in coronal sections of WT versus Hes5-overexpressing Tg
brains (C), and WT versus Hes5 KO brains (D), at E13.5. Note that the color development time was shorter for the data in D than in C. (E) Real-time RT-PCR for
Hmga1 and Hmga2 using total RNAs prepared from the neocortical regions of WT and Hes5 KO brains at E12.5, E14.5 and E18.5. (A,B,E) Gapdh was used
as an internal control. Data are mean±s.e.m. (n=3); *P<0.05, **P<0.01, ****P<0.0001 (Student’s t-test). Scale bars: 200 µm.
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(Fig. S5C,D). To reveal that the phenotype of Hes5 KO brain is
mediated by the upregulation of Hmga1/2, we performed
knockdown experiments by introducing a combination of
expression vectors of shRNA targeting Hmga1 (shHmga1) and
Hmga2 (shHmga2), in addition to scrambled shRNA control
vectors (shScrambled) (Kishi et al., 2012), in the VZ of the KO brain
by in utero electroporation at E13.5. When we performed birth date
analysis of Hmga1/2 knockdown cells by administering EdU at
E14.5, the switching delay was partially recovered by Hmga1/2
knockdown in the Hes5 KO brain (Fig. 6). Taken together, these
results suggest that the transition timing of layer-specific
neurogenesis and astrogenesis was regulated at least partly by the
expression levels of Hmga1/2 genes.
Hes5 repressed the promoter activity of Hmga genes
We next conducted reporter analysis using the Hmga1 (−5000 to
+28) and Hmga2 (−3111 to +56) promoters to test whether Hes5
downregulates the transcription of these genes (Fig. 7A).
Cotransfection of Hes5 expression vectors (pEF-HA-Hes5) with
reporter vectors (pHmga1-luc or pHmga2-luc) in NIH3T3 cells or
mouse neural stem (NS) cells significantly downregulated the
promoter activity of both Hmga1 and Hmga2 in a dose-dependent
manner (Fig. 7B), suggesting that Hes5 functions as a negative
regulator for transcription ofHmga1/2. Because the promoter activity
of Hmga1 was more effectively downregulated by Hes5 expression
compared to that of Hmga2, we focused on the Hmga1 promoter
for further analysis. We narrowed down the promoter sequence to the
regions responsible for the Hes5-mediated transcriptional repression.
Intriguingly, the promoter regions 2.5 kb and 3.9 kb upstream of the
ATG codon exhibited no apparent repression by Hes5, whereas the
4.6 kb promoter region exhibited Hes5-mediated transcriptional
repression (Fig. 7C,D), suggesting that the specified region
(between −4596 and −3910) and/or surrounding region contains
critical regulatory sites. It has been established that the Hes family of
bHLH factors repress transcription by binding to the N box
(CACNAG) and the class C site [CACG(C/A)G], and we found
one N box (−4547 to −4542) within the specified region. Therefore,
we constructedHmga1 reporter vectors with various modifications in
the N box, such as substitutions of 1, 2 or 5 nucleotides, or a deletion
of all six nucleotides in the N box sequence, and performed the
luciferase assay. However, these modifications resulted in only mild
effects onHmga1 promoter activity. Given that there are manyN box/
class C sites in the Hmga1 promoter, as shown in Fig. 7C, it is
possible that modifications in a fewN box/class C sites cannot induce
an effective de-repression. In addition, we found several E box
sequences in theHmga1 promoter region, suggesting that theHmga1
transcriptional activity could be indirectly regulated by Hes5 through
other regulatory sequences including E box.
Fig. 6. Knockdown experiments for Hmga1/2 in the Hes5 KO cortex. (A,C) Birth-date analysis of Hmga1/2 knockdown cells in the cortex of Hes5 KO brain.
Control vectors (shScrambled) or a combination ofHmga1/2 knockdown vectors (shHmga1 and shHmga2) together with pEF-EGFP vectors were introduced into
the VZ cells by in utero electroporation at E13.5. EdU was administered at E14.5, and the locations and fates of newly born neurons that coexpressed
GFP (green) and EdU (blue) were examined by the layer-specific markers Ctip2 (A, red) and Cux1 (C, red) at E18.5. (B,D) Graphs showing the proportions of
Ctip2+ cells (B) and Cux1+ cells (D) among cells colabeled with GFP and EdU. Total numbers of EdU+ cells counted for the quantification were ≥100 cells for
each analysis. Data are mean±s.e.m. (n=3); *P<0.05, **P<0.01 (Student’s t-test). Scale bars: 200 µm.
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Hes5 expression leads to suppression of the promoter
activity of Hmga and regulates the transition timing of
neocortical neurogenesis and gliogenesis
In the present study, we showed that the transition timing from deep
to superficial layer neurogenesis was shifted earlier and gliogenesis
was also accelerated with an earlier termination of the neurogenic
period via overexpression of Hes5 (Fig. 3); conversely, the
transition from deep to superficial layer neurogenesis and the
onset of gliogenesis were delayed in Hes5 KO mice (Fig. 4). These
results suggest that these transitions are not governed by the number
of cell divisions, given that the cell cycle progression was slower in
NSCs in the neocortical regions of the Tg brain (Fig. S1), which is in
line with a previous report that the transition in temporal identity of
NSCs can be controlled independently of cell cycle (Okamoto et al.,
2016). Therefore, we next addressed whether the machinery that
regulates the transition timing of neurogenesis and gliogenesis was
affected by Hes5 overexpression.
Temporal modification of the chromatin structure by the PcG
complex is known to be one of the key mechanisms regulating the
transition timing of neocortical neurogenesis and gliogenesis (Vogel
et al., 2006; Hirabayashi et al., 2009; Pereira et al., 2010; Morimoto-
Suzki et al., 2014; Corley and Kroll, 2015). It is also known that there
are two classes of PRC; PRC1 contains a ubiquitin ligase Ring1A/B
and PcG RING finger (PCGF) proteins, and PRC2 is composed of
Eed, Suz12 and a methyltransferase Ezh1/2 (Schwartz and Pirrotta,
Fig. 7. Reporter analysis using the
promoters of Hmga1/2. (A) Constructs
of reporter vectors containing the
promoter regions of Hmga1/2. Hmga1
(variant 1) promoter region (from −5000
to +28) or Hmga2 promoter region (from
−3111 to +56) was cloned into the
luciferase vector pGL4.10. (B) Luciferase
reporter assay using various amounts of
Hes5 expression vector (pEF-HA-Hes5).
Vectors were cotransfected in NIH3T3
cells or mouse NS cells, and the
luciferase activity was measured 24 h
later. (C) Truncated promoter regions of
the Hmga1 gene used for the reporter
assay. Locations of the putative N box
(CACNAG), the class C sites [CACG(C/
A)G], and N box/class C sites are
indicated by red, blue and green lines,
respectively. (D) Reporter assay using
various amounts of Hes5 expression
vector with truncated versions of Hmga1
reporter vectors. Vectors were
cotransfected in NIH3T3 cells and the
luciferase activity was measured 24 h
later. (B,D) Values were normalized to
those of the control samples. Data are
mean±s.e.m. (n=3); *P<0.05, **P<0.01,
***P<0.001 (Student’s t-test).
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2013). Morimoto-Suzki et al. reported that Ring1B suppresses Fezf2,
a fate determinant of Ctip2+ SCPNs [a class of deep layer (layer V)
neurons], and has a role in terminating the generation of Ctip2+
neurons (Morimoto-Suzki et al., 2014). These findings suggested that
Ring1B mediates the timed termination of Fezf2 expression and
switching from deep to superficial layer neurogenesis. Hirabayashi
et al. reported that the level of H3K27me3 at the Neurog1 promoter
region gradually increases over time, and that PcG proteins suppress
the Neurog1 locus during the astrogenic phase and mediate the
neurogenic-to-gliogenic fate switching in the developing cortex
(Hirabayashi et al., 2009). In the present study, expression levels of
Ezh2 and Eed were upregulated by Hes5 overexpression in the
neocortical regions only during the early neurogenic stages (Fig. 5A).
By contrast, expression levels of Hmga1/2 were markedly
downregulated in the neocortical regions of Hes5-overexpressing
Tg brain, but upregulated in the Hes5 KO brain (Fig. 5C-E).
Hmga proteins belong to the Hmg protein family, which consists
of nonhistone chromatin-associated proteins that regulate gene
expression by modulating chromatin structure (Ozturk et al., 2014).
Among their diverse functions, previous reports have uncovered
roles in self-renewal of NSCs (Nishino et al., 2008) and gliogenesis
during brain development (Sanosaka et al., 2008). It was
revealed that Hmga2 promotes self-renewal of NSCs by
decreasing p16Ink4a/p19Arf expression, but its expression declines
with age, partly due to the increasing expression of let-7b
microRNA (Nishino et al., 2008). Furthermore, it has been
reported that Hmga proteins are essential for the open chromatin
state in early-stage NSCs to maintain their neurogenic potential at
early developmental stages (Kishi et al., 2012). Overexpression of
Hmga proteins can retrieve the neurogenic potential even in late-stage
NSCs, and knockdown of Hmga1/2 promotes astrogenesis. In
addition, Fujii et al. reported that insulin-like growth factor 2 mRNA-
binding protein 2 (Igf2bp2) is one of the key mediators of Hmga
function that regulates the neurogenic potential of early-stage NSCs
(Fujii et al., 2013). Thus, it is likely that the downregulation of
Hmga1/2 accelerated the transition from deep to superficial layer
neurogenesis and the onset of astrogenesis in the Hes5-
overexpressing Tg cortex. This accelerated transition might be
partly due to the higher activity of PcG complexes (Fig. 5A), which
might have caused the reduction in Fezf2 expression (Fig. 2F,G),
resulting in earlier termination of the generation of Ctip2+ deep layer
neurons with precocious switching to production of Cux1+ superficial
layer neurons (Fig. 3) in the Tg cortex. In the present study, we
demonstrated that Hes5 expression leads to suppression of the
promoter activity of Hmga1/2 in reporter analyses (Fig. 7), although
we could not obtain evidence for the direct regulation ofHmga1/2 by
Hes5. Likewise, we could not demonstrate the direct regulation of
PcG genes, such as Ezh2,Eed andRing1B, byHes5 (data not shown),
in agreement with the modest effects of Hes5 overexpression on
expression levels of such PcG genes (Fig. 5A). However, it is possible
that the activity of the PcG complex can be modulated by Hmga or
other factors that are regulated by Hes5.
Precise control of Hes5 expression level is essential for
normal neocortical development
During neocortical development, expression of Hes5 is upregulated
after the onset of neurogenesis when NSCs start to receive strong
intercellular Delta-Notch signals from differentiating and mature
neurons (Hatakeyama et al., 2004). Our results indicate that the
timing and levels of Hes5 expression must be properly regulated in
order to maintain the precise temporal control of deep and
superficial layer neurogenesis and switching from neurogenesis to
gliogenesis in normal brain development. Otherwise, brain size and
neocortical organization become disturbed. It has been revealed that
Hes5 exhibits oscillatory expression in NSCs by a negative
autoregulation mechanism (Imayoshi et al., 2013), similarly to
Hes1 (Hirata et al., 2002), indicating the importance of the control of
Hes5 expression within appropriate levels to avoid its excessive
expression. Consistent with the above notion, we found that
expression levels of Hmga1/2 successively declined in NSCs of
mouse neocortical regions during the mid-gestation period between
E11.5 and E17.5, whereas Hes5 expression was gradually
upregulated during this period (Ohtsuka et al., 2011). Other
research groups have also demonstrated that HMGA2 expression
successively decreased, while HES5 expression gradually
increased, in the developing human brain during the mid-
gestation period (Patterson et al., 2014). Interestingly, Patterson
et al. reported a link between the let-7/HMGA2 circuit and Notch
signaling. They found that HMGA2 regulated fate decisions
between neurogenesis and gliogenesis in human NSCs via HES5,
and that the let-7 family of miRNAs downregulated HMGA2
expression. In addition, they demonstrated that knockdown of
HMGA2 by small interfering RNA led to a dramatic downregulation
of HES5, probably due to the blockade of access of NICD to the
HES5 promoter, while siRNA for HES5 (40% knockdown of HES5
expression) caused only a subtle increase in the HMGA2 expression
level. These results and the present findings together indicate a
crucial correlation between downstream effectors of the Notch
signaling pathway and epigenetic regulatory factors, although the
entire mechanism and biological significance of the correlation
between the two systems remain to be elucidated.
MATERIALS AND METHODS
Generation of transgenic mice
For the pNes-rtTA transgene, a rtTA-Advanced fragment excised from pTet-
On Advanced vector (Clontech) was subcloned between the Nes promoter
(5.8 kb) and polyadenylation sequence of SV40 with the second intron
(1.7 kb) of the Nes gene. For the TRE-Hes5/d2EGFP transgene, mouse
Hes5 and d2EGFP (Clontech) cDNAs were inserted into pTRE-Tight-BI
vector (Clontech) (Fig. 1A). Two Tg mouse lines were generated using each
transgene and maintained on the ICR background. Both lines were crossed
and doxycycline hyclate (Sigma-Aldrich; 2.0 mg/ml) in drinking water with
5% sucrose was continuously administered to pregnant mice from E9.5 until
sacrifice. Images of whole bodies with GFP fluorescencewere obtained with
a MZ16FA fluorescence stereo microscope equipped with a DFC300 FX
digital camera (Leica). Animal experiments were carried out according to
the guidelines for animal experiments at Kyoto University.
Immunohistochemistry
Immunohistochemistry was performed as described previously (Ohtsuka
et al., 2011). Brains were fixed in 4% paraformaldehyde, incubated
overnight with 20% (w/v) sucrose in PBS at 4°C, embedded in OCT
compound and cryosectioned at 16 μm thickness. Sections were blocked
with 5% normal goat serum in 0.1% Triton X-100 in PBS for 1 h at room
temperature. Primary antibodies diluted in 1% normal goat serum/0.1%
Triton X-100 in PBSwere applied overnight at 4°C. Primary antibodies used
in this study are listed in Table S1. Alexa Fluor-conjugated secondary
antibodies (Molecular Probes; 1:200) were applied for 2 h at room
temperature to detect primary antibodies. DAPI (4′,6-diamidino-2-
phenylindole) (Sigma-Aldrich) was used for nuclear staining. Images
were analyzed using a LSM510 confocal microscope (Zeiss).
In situ hybridization
Preparation of digoxygenin-labeled RNA probes and in situ hybridization
were performed as described previously (Ohtsuka et al., 2011). The coding
sequences of Hes5 (NM_010419.4), Hes1 (NM_008235.2), Neurog2
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(NM_009718.2), Ascl1 (NM_008553.4), Fezf2 (NM_080433.3), Hmga1
(NM_016660.3), Hmga2 (NM_010441.2), Ezh2 (NM_007971.2) and Eed
(NM_021876.3) were used as templates for the RNA probes.
Quantitative real-time RT-PCR
Total RNA was prepared from the neocortical regions of mouse brains
(Ohtsuka et al., 2011). Reverse transcription was performed using total
RNA as described previously (Tan et al., 2012). Gapdh was used as an
internal control. PCR primers are listed in Table S2.
BrdU incorporation assay
BrdU (Sigma-Aldrich; 50 μg BrdU/g of body weight) was injected
intraperitoneally to pregnant mice 30 min before sacrifice. The BrdU+
cells were detected by immunohistochemistry as described previously (Tan
et al., 2012).
EdU birthdating
EdU (Molecular Probes; 12.5 μg EdU/g of body weight) was injected
intraperitoneally to pregnant mice at E12.5, E13.5 or E14.5, and the
offspring were analyzed at E18.5. EdU-labeled cells were detected by a
fluorogenic click reaction (Salic and Mitchison, 2008). The numbers of
EdU-labeled cells positive and negative for the layer marker were manually
counted in the immunostained sections, and the proportions of EdU-labeled
cells positive for the layer marker among total EdU-labeled cells were
calculated. At least three sections of three mice were used for quantification.
Knockdown experiment
Knockdown experiments were performed by introducing a combination of
expression vectors of shRNA targeting Hmga1 ( pSiren-EGFP-shHmga1)
and Hmga2 ( pSiren-EGFP-shHmga2), in addition to scrambled shRNA
control vectors ( pSiren-EGFP-shScrambled) (Kishi et al., 2012), in the VZ
of Hes5 KO brain by in utero electroporation at E13.5. pSiren-EGFP-
shHmga1, pSiren-EGFP-shHmga2 and pSiren-EGFP-shScrambled vectors
were kindly provided by Dr Yusuke Kishi and Dr Yukiko Gotoh
(The University of Tokyo). In utero electroporation was performed as
described previously (Ohtsuka et al., 2011).
Plasmids
For the Hes5 expression vector ( pEF-HA-Hes5), a hemagglutinin (HA)-
tagged coding sequence ofHes5 (NM_010419.4) was cloned into pEF-MM
vector. For the luciferase reporter constructs ( pHmga1-luc and pHmga2-
luc), a 5.0-kb fragment of the Hmga1 (variant 1) (NM_016660.3) promoter
region (from−5000 to +28, relative to the ATG codon in exon 2) or a 3.2-kb
fragment of the Hmga2 (NM_010441.2) promoter region (from −3111 to
+56, relative to the ATG codon in exon 1) was inserted into the multiple
cloning site of the pGL4.10 luciferase vector (Promega). For the truncated
versions of Hmga1 reporters, −4596 bp, −3910 bp, −2508 bp, −2000 bp,
−1506 bp and −1003 bp upstream promoter regions relative to the ATG
codon were cloned into the pGL4.10 luciferase vector.
Cell culture and transfection
NIH3T3 cells were cultured in DMEM and 10% FBS. Neural stem (NS)
cells were originally established from basal forebrain regions of perinatal
mice (Imayoshi et al., 2013) and maintained using a NS cell culture method
as described previously (Conti et al., 2005) with minor modifications.
Briefly, NS cells were plated in serum-free medium (DMEM/F12)
supplemented with 1% N2-MAX medium (R&D Systems), 1% Penicillin/
Streptomycin (Nacalai), 10 ng/μl of both EGF and basic FGF (Invitrogen),
and 4 μg/ml laminin (Sigma-Aldrich). For transfection, NIH3T3 cells or NS
cells were cultured at subconfluence and transfected using ViaFect
transfection reagent (Promega) according to the manufacturer’s instructions.
Reporter assay
The luciferase reporters of Hmga1 or Hmga2 (pHmga1-luc or pHmga2-luc)
(0.1 μg) and the Hes5 expression plasmids (pEF-HA-Hes5) (0.05-0.4 μg) were
transfected into NIH3T3 cells or mouse NS cells along with pRL-SV40
(Promega) to normalize the transfection efficiency. The luciferase assay was
performed 24 h post-transfection as described previously (Sakamoto et al., 2003).
Statistical analysis
Each value was obtained from at least three independent samples. Statistical
significance was evaluated by Student’s t-test. Data are presented as mean±
s.e.m.
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Table S1. Primary antibodies 
 
Antigen Host Manufacturer  Catalogue No. Dilution 
     
GFP chicken Molecular Probes A11122 1:500 
Hes1 rabbit Cell Signaling  #11988S 1:100 
Pax6 rabbit Covance PRB-278P 1:200 
Tbr2 rabbit Abcam ab23345 1:500 
Tuj1 mouse Covance MMS-435P 1:1000 
NeuN mouse Merck Millipore MAB337 1:500 
Tbr1 rabbit Abcam   ab31940 1:400 
Ctip2 rat Abcam ab18465 1:500 
Cux1 rabbit Santa Cruz sc-13024 1:100 
GFAP rabbit DAKO Z0334 1:500 
GFAP rabbit Sigma-Aldrich G9269 1:400 
BrdU rat Serotec MCA2060 1:500 
Ki67 mouse BD Pharmingen 556003 1:100 
pH3 mouse Sigma-Aldrich  H6409 1:500 
Olig2 mouse EMD Millipore MABN50 1:500 
Cleaved caspase-3  rabbit Cell Signaling #9661S 1:500 
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Table S2. qRT-PCR primers 
 
Gene  Primer  Sequence 
   
Hes1 Fw (Forward) 5′-TGAAGGATTCCAAAAATAAAATTCTCTGGG-3′  
 Rv (Reverse) 5′-CGCCTCTTCTCCATGATAGGCTTTGATGAC-3′  
   
Hes5 Fw 5′-AAGTACCGTGGCGGTGGAGATGC-3′ 







 Rv 5'-CTGTGAAGTGGAGTCCG-3' 
   
Ascl1 Fw 5′-GCCACCAGAATGACTTCAGCAC-3′  
 Rv 5′-AAGGCAACCTATGGGAACCAAC-3′  
   
Tbr1 Fw 5′-CCGAGTCCAGACGTTCACTT-3′  
 Rv 5′-GCCCGTGTAGATCGTGTCAT-3′  
   
Ctip2 Fw 5′-ACGACAAGGTCCTGGACAAG-3′  
 Rv 5′-TTGTGCAAATGAGCTGGAAG-3′ 
   
Fezf2 Fw 5′-CTCTACTGACAGCAAACCCA-3′ 
 Rv 5′-CTTTGCACACAAACGGTCT-3′ 
   
Cux1 Fw 5′-CAGCGCTTATTTGGGGAGACC-3′  
 Rv 5′-TGGAACCAGTTGATGACGGTG-3′ 
   
GFAP Fw 5'-GGCGCTCAATGCTGGCTTCA-3′ 
 Rv 5′-TCTGCCTCCAGCCTCAGGTT-3′ 
   
Ezh2 Fw 5′-TTTGCTAATCATTCAGTAAATCCAAAC-3′ 
 Rv 5′-GCAAAGATGCCTATCCTGTG-3′ 
   
Eed Fw 5'-GTATGTTTGGGATTTAGAAGTAGAAGA-3' 
 Rv 5'-CTACTGAAACTGGTTTGTCGAA-3' 
   
Ring1B Fw 5′-AGTTACAACGAACACCTCAG-3′ 
 Rv 5′-TCCAAACAAATTGGGCACAT-3′ 
   
Hmga1 Fw 5'-CATCTCACTCTGACAAGGC-3′ 
 Rv 5'-CACCCGGTGATACTTTGG-3′ 
   
Hmga2 Fw 5'-AGAACTAGACACTACTCTCCTT-3′ 
 Rv 5'-CGAGCATAACCTATTCTGGTTT-3′ 
   
Gapdh Fw 5′-TGGGTGTGAACCACGA-3′  
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